CNBX

As of August 31, 2025, we had one employee and several consultants.
With the exception of our CFO, Uri Ben Or, our management team lacks significant public company experience, which could impair our ability to comply with these legal, accounting, and regulatory requirements.
Management assessed the effectiveness of the Company’s internal controls over financial reporting as of August 31, 2025, based on the framework in Internal Control—Integrated Framework (COSO 2013) issued by the Committee of Sponsoring Organization of the Treadway Commission.
At August 31, 2025, our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) and concluded that, subject to the inherent limitations identified in Item 9A of Part II of our Annual Report on Form 10-K for the fiscal year ended August 31, 2025, our disclosure controls and procedures were not effective as of that date.
An evaluation was conducted under the supervision and with the participation of our management of the effectiveness of the design and operation of our disclosure controls and procedures as of August 31, 2025.
Such officer also confirmed that there was no change in our internal control over financial reporting during the six-month period ended August 31, 2025 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Between September 1 st , 2024, and August 31 st , 2025, the sales price of our stock on the OTCQB ranged from a low of $0.0003 per share to a high of $0.015 per share.
As of August 31, 2025, Cannabics Inc., a Delaware corporation owns 3.2% of our common stock.

Gone since FY2024

As of August 31, 2024, we had two employees and several consultants.
With the exception of our CFO, Elkana Amitai , our management team lacks significant public company experience, which could impair our ability to comply with these legal, accounting, and regulatory requirements.
Management assessed the effectiveness of the Company’s internal controls over financial reporting as of August 31, 2024, based on the framework in Internal Control—Integrated Framework (COSO 2013) issued by the Committee of Sponsoring Organization of the Treadway Commission.
At August 31, 2024, our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) and concluded that, subject to the inherent limitations identified in Item 9A of Part II of our Annual Report on Form 10-K for the fiscal year ended August 31, 2024, our disclosure controls and procedures were not effective as of that date.
An evaluation was conducted under the supervision and with the participation of our management of the effectiveness of the design and operation of our disclosure controls and procedures as of August 31, 2024.
Such officer also confirmed that there was no change in our internal control over financial reporting during the six-month period ended August 30, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Between September 1 st , 2023, and August 31 st , 2024, the sales price of our stock on the OTCQB ranged from a low of $0.0055 per share to a high of $.098 per share.
As of August 31, 2024, Cannabics Inc., a Delaware corporation owns 3.2% of our common stock.

Sentence-level comparison of Item 1A in the two most recent 10-Ks (FY2024 ↗, FY2025 ↗). A reworded sentence counts as one dropped and one added, so heavy edits read as low “kept”. Headings and page furniture are stripped; nothing is summarised by a model.

Watch CNBX. Know when insiders buy.

One email the day a filing lands. Free.